Austin Breast Center Offers BrevaGen Breast Cancer Risk Dx
The Breast Center of Austin this week announced that patients being treated at the facility will have access to BrevaGen, a test that assesses risk of developing non-familial or sporadic breast cancer.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
